Apex Biotechnology

Apex Biotechnology Interest Coverage

The Interest Coverage Ratio of Apex Biotechnology (1733.TW) as of Nov 22, 2026 is 5.70. In the previous year, Interest Coverage Ratio was 10.25 — a change of -44.37% (lower).

Interest Coverage

5.70

YoY

-44.37%

Last updated:

Interest Coverage Ratio of Apex Biotechnology is 2024 5.70 . Interest Coverage Ratio of Apex Biotechnology was 2023 10.25 . It decreases by -44.37% lower compared to the previous year.

The Apex Biotechnology Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
3.47 TWD
Jan 1, 2018
23.52 TWD
Jan 1, 2019
5.24 TWD
Jan 1, 2020
27.95 TWD
Jan 1, 2021
5.18 TWD
Jan 1, 2022
4.47 TWD
Jan 1, 2023
10.25 TWD
Jan 1, 2024
5.70 TWD
The Apex Biotechnology Interest Coverage history
YEARInterest CoverageYoY
5.70-44.37%
10.25+129.48%
4.47-13.81%
5.18-81.45%
27.95+433.08%
5.24-77.71%
23.52+578.34%
3.47-58.58%
8.37-49.85%
16.69+45.13%
11.50—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Apex Biotechnology Stock analysis

What does Apex Biotechnology do? Apex Biotechnology Corp is a Taiwan-based company specializing in the development of innovative biotechnology products. The company was founded in 2002 and offers a wide range of products and services to its customers. Apex Biotechnology Corp began with the production of specialty chemicals and enzymes for research and development purposes. Over the years, the company has expanded its business and focused on the development of diagnostic products, dietary supplements, and pharmaceutical products. The company's business model focuses on the development and marketing of biotechnology products. Apex Biotechnology Corp has established advanced research centers and works closely with research institutions and pharmaceutical companies worldwide to develop innovative solutions. The company operates in various sectors, including diagnostics, dietary supplements, and pharmaceuticals. It offers a diverse range of products, including enzyme immunoassays, lateral flow tests, dietary supplements, and pharmaceuticals. Apex Biotechnology Corp has built strong relationships with research institutions and pharmaceutical companies and has successfully marketed its products internationally. Apex Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apex Biotechnology stock

Interest Coverage Ratio of Apex Biotechnology is 5.70 in 2024.

Interest Coverage Ratio of Apex Biotechnology changed from 10.25 to 5.70, representing a -44.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Apex Biotechnology since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Apex Biotechnology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Apex Biotechnology

All Key Metrics — Apex Biotechnology